United Therapeutics amends bylaws to enhance stockholder proposal and nomination procedures

UNITED THERAPEUTICS Corp

Amendments require additional background info on proposing stockholders and nominees, and representation on solicitation intentions.
Updates procedural mechanics for adjourned meetings, inspectors of election, and proxy revocability.
Eliminates stockholder list inspection at meetings; opts out of DGCL Section 116 for written delivery of notices.
Certificates and uncertificated shares must conspicuously state company is a public benefit corporation.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

UNITED THERAPEUTICS Corp: Adopted Tenth Amended and Restated Bylaws with various amendments including enhanced stockholder proposal and director nomination procedures, adjourned meeting mechanics, proxy rules, and technical changes (effective 2023-04-20).

Change: bylaw amendment
Effective: 2023-04-20

Exact text from the filing

On April 20, 2023, the Board of Directors (the “ Board ”) of United Therapeutics Corporation (the “ Company ”) approved and adopted the Company’s Tenth Amended and Restated Bylaws (as amended and restated, the “ Bylaws ”), which became effective the same day.

View on SEC.gov

Browse all governance changes →

UNITED THERAPEUTICS Corp filing history →

Source: SEC EDGAR

accession 0001104659-23-047912

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.